Developing cell therapy for Parkinson's disease
Official title: IND-enabling studies for cell therapy in Parkinson's disease
Funded at Neoneuron, LLC · NIH-10932228 · Data updated 2026-11-12
This study is exploring a new way to use special cells to help treat Parkinson's disease by improving how these cells are delivered to the brain, with the hope of making life better for patients living with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Neoneuron, LLC NIH-funded |
| Lab location | 1 site (San Antonio, UNITED STATES) |
| Project start | September 20, 2023 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $234,772 |
| NIH project number | 5R41NS132678-02 |
| Project ID | NIH-10932228 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who are diagnosed with Parkinson's disease and experiencing significant symptoms.
✕Less likely to help
Patients with Parkinson's disease who are not eligible for cell therapy or those with advanced stages of the disease may not benefit from this research.
What this research studies
This research focuses on creating a new cell therapy approach for treating Parkinson's disease, which currently has no cure. The study aims to improve the delivery and effectiveness of cell transplantation using induced pluripotent stem cells (iPSCs) to restore dopamine-producing neurons in the brain. By refining the cellular products and clinical protocols, the research seeks to enhance patient outcomes and address the limitations of existing treatments. Patients may benefit from innovative therapies that could significantly improve their quality of life.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking treatment option that restores function and alleviates symptoms for Parkinson's disease patients.
How similar studies have gone: Previous studies have shown promise in using cell transplantation for Parkinson's disease, but this approach with iPSCs is relatively novel and aims to address existing challenges.
Where this research is happening
-
Neoneuron, LLC
San Antonio, United States Active
Researchers
- Principal investigator: Daadi, Marcel — Neoneuron, LLC
- Study coordinator: Daadi, Marcel
Related research
Other NIH-funded projects on the same topics.
-
Gut-brain clues in Parkinson’s disease: supplement to a large registry
A plant-wide supplement to an NIH program will enroll people with Parkinson’s, with and without GI symptoms, plus healthy controls, to study how gut function, brain signals, and sleep rhythms relate to Parkinson’s symptoms.
-
Gut-brain connections in Parkinson’s disease: how the gut and environment shape symptoms
A Mayo Clinic team is studying how gut problems, environmental factors, and genetics together influence Parkinson’s disease and its GI symptoms to find biomarkers and better understanding of the disease.
-
Gut-brain communication in Parkinson’s disease for better symptoms and daily life
This project enrolls people with Parkinson’s disease and healthy controls to build a big registry and study how gut function, brain signals, sleep, and circadian rhythms relate to PD symptoms.
-
Gut microbiome and Parkinson's disease: how gut bugs relate to symptoms and progression
A multi-year study will look at gut bacteria and related markers in people with Parkinson’s disease to understand how the gut-brain connection may influence symptoms and progression.
-
Gut-Brain Axis in Parkinson’s Disease: biomarkers and procedures to track progression
A patient-focused program to study how gut health and the brain interact in Parkinson’s disease using biomarkers and clinical procedures.
-
Understanding posture and movement in Parkinson’s patients to reduce falls
A study using wearable sensors to track real-world balance and movement in people with Parkinson’s disease to help prevent falls.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.